Editorial: C-PEPTIDE PROFILING AND TYPE 2 DIABETES TREATMENT DECISIONS

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Endocrine Practice

• Publication date

  1999-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4158/EP.5.6.371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Troglitazone Lowers Islet Fat and Restores Beta Cell Function of Zucker Diabetic Fatty Rats*

  1998cited by this paper
• Beneficial effect of long-term combined treatment with voglibose and pioglitazone on pancreatic islet function of genetically diabetic GK rats.

  1998cited by this paper
• Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus

  1998cited by this paper
• Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

  1998cited by this paper
• Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus.

  1998cited by this paper
• Short-term intensive insulin therapy in insulin-requiring diabetes: effectiveness and factors predicting success.

  1997cited by this paper
• Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.

  1997cited by this paper
• The Classification of Diabetes by Clinical and C-Peptide Criteria: A prospective population-based study

  1997cited by this paper
• Troglitazone Improves Defects in Insulin Action , Insulin Secretion , Ovarian Steroidogenesis , and Fibrinolysis in Women with Polycystic Ovary Syndrome *

  1997cited by this paper
• Outcome of metformin-facilitated reinitiation of oral diabetic therapy in insulin-treated patients with non-insulin-dependent diabetes mellitus.

  1997cited by this paper
• Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione Troglitazone

  1997cited by this paper
• Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity.

  1997cited by this paper
• Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy

  1996cited by this paper
• Effect of Troglitazone on Insulin Sensitivity and Pancreatic β-Cell Function in Women at High Risk for NIDDM

  1996cited by this paper
• Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

  1996cited by this paper
• Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.

  1996cited by this paper
• Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

  1994cited by this paper
• Insulin plus a sulfonylurea agent for treating type 2 diabetes.

  1991cited by this paper
• A comparison of childhood and adult type I diabetes mellitus.

  1989cited by this paper

• One-hour meal tolerance test to assess withdrawal of insulin therapy in overweight patients with type 2 diabetes.

  2001cites this paper